27 related articles for article (PubMed ID: 35086099)
1. The effects of thymidylate synthase 3'UTR genotype on methylation of tumor-specific genes promoter in 22 colorectal cancer patients from southern Iran.
Niknam M; Naghibalhossaini F; Zamani M; Hosseini SV; Mokarram P
Mol Biol Res Commun; 2024; 13(2):89-102. PubMed ID: 38504782
[TBL] [Abstract][Full Text] [Related]
2. Correction to: Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer.
Oncologist; 2024 Jan; 29(1):e166. PubMed ID: 38000087
[No Abstract] [Full Text] [Related]
3. Association of methylenetetrahydrofolate reductase (MTHFR 677C>T) and thymidylate synthase (TSER and TS 1494del6) polymorphisms with premature ovarian failure in Korean women.
Rah H; Jeon YJ; Choi Y; Shim SH; Yoon TK; Choi DH; Cha SH; Kim NK
Menopause; 2012 Nov; 19(11):1260-6. PubMed ID: 22713864
[TBL] [Abstract][Full Text] [Related]
4. Distribution of the most common polymorphisms in TYMS gene in Slavic population of central Europe.
Pastorakova A; Chandogova D; Chandoga J; Luha J; Bohmer D; Malova J; Braxatorisova T; Juhosova M; Reznakova S; Petrovic R
Neoplasma; 2017; 64(6):962-970. PubMed ID: 28895423
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ
Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929
[TBL] [Abstract][Full Text] [Related]
6. Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients.
Adleff V; Hitre E; Köves I; Orosz Z; Hajnal A; Kralovánszky J
Int J Cancer; 2004 Mar; 108(6):852-6. PubMed ID: 14712487
[TBL] [Abstract][Full Text] [Related]
7. Thymidylate Synthase Polymorphisms and Risk of Lung Cancer among the Jordanian Population: a Case Control Study.
Qasem WA; Yousef AM; Yousef M; Manasreh I
Asian Pac J Cancer Prev; 2015; 16(18):8287-92. PubMed ID: 26745074
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism in Thymidylate Synthase Gene Predicts Survival and Toxicity in North Indian Lung Cancer Patients Undergoing Platinum-Based Doublet Chemotherapy.
Sharma P; Singh N; Sharma S
Oncology; 2022 Jan; ():. PubMed ID: 35086099
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis.
Weng Y; Zhang J; Tang X; Xie X; Chen G
Leuk Lymphoma; 2012 Jul; 53(7):1345-51. PubMed ID: 22166040
[TBL] [Abstract][Full Text] [Related]
10. The association between two polymorphisms in the TS gene and risk of cancer: a systematic review and pooled analysis.
Zhou JY; Shi R; Yu HL; Zeng Y; Zheng WL; Ma WL
Int J Cancer; 2012 Nov; 131(9):2103-16. PubMed ID: 22307944
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review.
Wang Z; Chen JQ; Liu JL; Qin XG; Huang Y
BMC Gastroenterol; 2012 Sep; 12():137. PubMed ID: 23020798
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase pharmacogenetics in colorectal cancer.
Marsh S; McLeod HL
Clin Colorectal Cancer; 2001 Nov; 1(3):175-8; discussion 179-81. PubMed ID: 12450432
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
